Citation Impact
Citing Papers
Immunosuppression in renal transplantation II. Corticosteroids, antilymphocyte globulin, and OKT3
1991
Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine
1987
Ultrasensitive Antibody Detection by Agglutination-PCR (ADAP)
2016 StandoutNobel
Vitamin D Deficiency
2007 Standout
Aciclovir
1994
Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes
1996 StandoutNobel
Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient
2005
Reshaping human antibodies for therapy
1988 StandoutNatureNobel
Interleukin-2–Receptor Blockade with Daclizumab to Prevent Acute Rejection in Renal Transplantation
1998 Standout
Randomized Controlled Trial of a Monoclonal Antibody against the Interleukin-2 Receptor (33B3.1) as Compared with Rabbit Antithymocyte Globulin for Prophylaxis against Rejection of Renal Allografts
1990
CD3-specific antibody-induced active tolerance: from bench to bedside
2003
Nocardiosis at the Turn of the Century
2009 Standout
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
The preterm parturition syndrome
2006 Standout
Risk Factors, Clinical Characteristics, and Outcome of Nocardia Infection in Organ Transplant Recipients: A Matched Case-Control Study
2007 Standout
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006 Standout
Hepatitis E Virus and Chronic Hepatitis in Organ-Transplant Recipients
2008 Standout
Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells
2004 StandoutNobel
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
The Use of Therapeutic Drug Monitoring to Optimise Immunosuppressive Therapy
1996
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Pharmaceutical and therapeutic Potentials of essential oils and their individual volatile constituents: a review
2007 Standout
Oral CD3-specific antibody suppresses autoimmune encephalomyelitis by inducing CD4+CD25−LAP+ T cells
2006
Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996
2000 Standout
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
Outcome of cadaveric renal transplantation by induction treatment in the cyclosporine era
1996
Human anti-mouse antibody response to the injection of murine monoclonal antibodies against IL-6
1994
Magnesium in Man: Implications for Health and Disease
2014 Standout
CD4+CD25−LAG3+regulatory T cells controlled by the transcription factor Egr-2
2009 StandoutNobel
Infections in solid-organ transplant recipients
1997
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules.
1988
Varicella-zoster virus
1996 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Human Anti-Animal Antibody Interferences in Immunological Assays
1999
Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
2003 Standout
Aspergillus fumigatusand Aspergillosis
1999 Standout
A novel strategy for generating monoclonal antibodies from single, isolated lymphocytes producing antibodies of defined specificities.
1996
A Novel Mutation in CD83 Results in the Development of a Unique Population of CD4+ T Cells
2004 StandoutNobel
PREVENTION OF REJECTION OF KIDNEY TRANSPLANTS BY MONOCLONAL ANTIBODY DIRECTED AGAINST INTERLEUKIN 2
1987
Bone metabolism and disease in chronic kidney disease
2003
Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen.
1987
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
2000
Works of N Chkoff being referenced
AZATHIOPRINE HEPATITIS IN KIDNEY TRANSPLANT RECIPIENTS
1996
ONE-MONTH PROPHYLACTIC USE OF OKT3 IN CADAVER KIDNEY TRANSPLANT RECIPIENTS
1988
Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3.
1986
Disorders of calcium and phosphorus metabolism after successful kidney transplantation.
1983
Acyclovir in preventing cytomegalovirus infection in kidney transplant recipients: a case-controlled study.
1993
PROPHYLACTIC USE OF OKT3 MONOCLONAL ANTIBODY IN CADAVER KIDNEY RECIPIENTS UTILIZATION OF OKT3 AS THE SOLE IMMUNOSUPPRESSIVE AGENT
1986
Acyclovir in preventing cytomegalovirus infection in kidney transplant recipients: A case-controlled study
1993
A randomized trial comparing the efficacy of OKT3 used to prevent or to treat rejection.
1989